Medical Innovation Exchange

Intellia's gene editing therapies both post early successes as evidence grows for CRISPR potential

https://www.fiercebiotech.com/biotech/intellias-gene-editing-therapy-attr-sees-more-phase-1-success-ahead-pivotal-us-trial

Leave a Comment

Your email address will not be published.

Leave the field below empty!